Publisher Correction: Phage therapy's latest makeover.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31114034.
- Also identified by DOI 10.1038/s41587-019-0158-3.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the version of this article initially published, we listed 13 companies that were developing phage therapies a decade ago and stated that only a few are still active today. Missing from the active list was Phico Therapeutics of Bourn, UK. In addition, a location (Canada) has been added for PhageTech, and "Last May" has been changed to "In May" at the beginning of the article. The errors have been corrected in the HTML and PDF versions of the article.